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Substance-ﬂow analysisA new approach is conceptualized for measuring small-area human populations by using biomarkers in sewage.
The basis for the concept (SCIM: Sewage Chemical-InformationMining) is supported by a comprehensive exam-
ination and synthesis of data published across several disciplines, including medicine, microbiology, clinical
chemistry, and environmental science. Accurate measures of human populations are fundamental to numerous
disciplines, including economics, marketing, politics, sociology, public health and safety (e.g., disease manage-
ment; assessment of natural hazards; disaster prevention and response), quality of life, and the environment.
Knowing the size, distribution, and ﬂow of a small-area (local) population facilitates understanding the numer-
ous and complex linkages and interactions between humans and the environment. Examples include material-
ﬂow (substance-ﬂow) analysis, determining the magnitude of per capita contribution of pollutant loadings to
watersheds, or forecasting future impacts of local populations on the environment or a population's demands
on resources. While no deﬁnitive approach exists for measuring small-area populations, census-taking is a
long-established convention. No approach exists, however, for gauging small-area populations in real-time, as
none is able to capture population dynamics, which involve transient changes (e.g., daily inﬂux and efﬂux)
and lasting changes (e.g., births, deaths, change in residence). Accurate measurement of small-area populations
in real time has never been possible but is essential for facilitating the design of more sustainable communities.
Real-time measurement would provide communities the capability of testing what-if scenarios in design and
policy decisions.
After evaluation of a range of biomarkers (including the nitrogenous waste product creatinine, which has been
long used in clinical chemistry as a parameter to normalize the concentrations of other urinary excretion
products to account for urine dilution), the biomarker with the most potential for the SCIM concept for real-
time measurement of population was determined to be coprostanol - the major sterol produced by microbial
reduction of cholesterol in the colon.
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1.1. Small-area populations and their measurement
The critical importance of knowing the size of discrete human
populations was clear millennia ago with rulers who needed to
gauge the pool of those who could pay taxes or serve in militia; the
Bible's book of Numbers is but one example. Today the importance
continues to grow, driven by questions germane to economics, mar-
keting, politics, sociology, public health and safety (e.g., epidemiology,
disease management; assessment of natural hazards; disaster preven-
tion and response), quality of life, and the environment. Population
density and its ﬂow play major roles in demands on infrastructure
and ecological services, as well as serving as a major environmental
stressor itself.
City planning (public requirements for infrastructure, such as
land, transportation, schools, communication, drinking water and
wastewater treatment and distribution, waste disposal, emergency
services, and healthcare), formulation of public policy, and resource
allocation often rely on understanding not just the size and distribution,
but also the ﬂow of small-area (local) populations. Understanding the
size, distribution, and dynamics of local populations is essential for
modeling future projections and forecasting. It also facilitates under-
standing the numerous and complex linkages and interactions be-
tween humans and the environment, such as for material-ﬂow
(substance-ﬂow) analysis (Baker, 2009) – especially the ﬂow of pol-
lutants – and for the study of sustainability and environmental
justice.
As a key denominator term in a wide array of statistics and ratios
involved with various calculations, the error associated with popula-
tion size is often overlooked relative to the numerator (Aickin et al.,
1991; Thunhurst, 2009). Given the numerous integral roles played by
population statistics, the methodologies fundamental for measuring or
estimating small-area populations are surprisingly limited; none is an
accepted standard and all can be prone to considerable error. Because
of the complexities involvedwith population estimation, advancements
in the range of available tools have been incremental. New paradigms
have not emerged. Themost recent improvements have been the appli-
cation of remote-sensing and geographic information system tech-
niques to extant census data (e.g., for small-area populations, where
data on housing units and persons per household can be applied). Sum-
mary of the existing approaches and their complexity and limitations is
widely available (e.g., Deng et al., 2010). The general approaches for
census taking – and its associated problems and limitations – have
also been summarized in numerous documents (e.g., Smith and
Morrison, 2005; Swanson and McKibben, 2010; US Census Bureau,
2011; Wilmoth, 2004).
Population size is clearly a key parameter in a broad spectrum of
processes fundamental to governance. Accurate data are required to
make sound decisions involved with planning and forecasting, policymaking, and resource allocation. Accurate data are necessary for guid-
ing development, assessing demand on services and infrastructure,
and informing legislation. Current methodologies are based on public
surveys (such as census taking), augmented with a wide array of
demographic statistics, such as tourism. Census taking, however, pro-
vides estimates that quickly become increasingly outdated and can-
not be easily updated to accommodate change — births, deaths, and
migration (movement); this is exacerbated by the fact that census
taking is infrequent because of its cost. Complex models (e.g., cohort
survival models) relying on numerous assumptions and estimates are
therefore required to interpolate or extrapolate in order to generate
postcensal or intercensal population estimates (e.g., Dennis et al.,
2007).
Census taking uses one of two basic approaches for estimating
geographically located populations. These result in data applicable
to two different purposes — estimates of de jure population or de
facto population. A de jure population comprises all “usual” residents,
mainly those with formal residences. A de facto population comprises
all those who happen to be present, regardless of the location of their
formal or usual residence. A de facto population therefore includes all
non-residents (e.g., commuters, visitors, tourists) and excludes all
permanent residents who happen to be absent (Bell, 2004; Wu
et al., 2005). There can be ambiguity in deﬁning the two types, and
delineating between them in practice can become convoluted.
For the purposes of environmental impact, the de facto population
can be considered the more signiﬁcant parameter, as it reﬂects the
actual demands on local services. With an increasingly transient and
mobile society, estimating de facto population assumes increasing
importance. Furthermore, one particular aspect of measuring popula-
tion size and distribution has been growing in importance — the need
for real-time measurement, which essentially yields estimates of the
“true” de facto population. Conventional estimation approaches all
rely on existing data (e.g., census) to drive computational and statis-
tical extrapolations and projections. Although accurate measurement
of small-area populations in real time is essential for facilitating the
design of more sustainable communities, it is currently not possible.
Real-time measurement would provide communities the capability
for the ﬁrst time of quickly testing what-if scenarios in design and
policy decisions.
With this said, alternative approaches for measuring population
size continue to emerge but have fundamental limitations excluding
them from the uses considered here. For example, monitoring of
cell (mobile) phone use has been explored as a means of measuring
urban population density and ﬂow (e.g., Dan and He, 2010). The utility
of this approach is limited by the variable extent of cell phone
possession (market penetration) and does not directly correspond
with de facto local population (e.g., the very young do not use cell
phones); whether a cell phone is actually in use depends on user behav-
ior. With these problems aside, cell phone use would likely measure a
sizeable de facto non-local population (such as commuters) that is
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resulting population estimates useless for a major application of the
concept presented here, which will entail the acquisition of biomarker
data from sewage (see Section 7.3).
1.2. Objectives
Presented here is a concept for measuring dynamic, small-area
populations in real time. The concept relies on monitoring raw
sewage for the combined excretion of a biomarker known to have a
relatively stable per capita rate of elimination in urine or feces. The
approach ensures that the entire actual (de facto) population is sam-
pled and that the absent portion of the de jure population is excluded.
This contrasts sharply with the census approach, which acquires a
static snapshot estimate and usually succeeds in only capturing a
portion of the population. This new approach could also provide a vastly
improved accounting of transient population mobility. The principles
and foundation of the concept are presented, along with its limitations
and weaknesses. Preliminary proof-of-principle is also discussed. With
follow-on, ﬁeld-based studies, this measurement methodology could
be continually reﬁned. Amajor objective of this work is to foster discus-
sion and catalyze further investigation designed to evaluate the propo-
sal's merits.
The concept would be suitable for the vast majority of metropolitan
and urban small-area populations. It might provide not just real-time
estimates, but also require considerably less skill and expense com-
pared with all conventional public-survey approaches such as a census.
The concept also has the potential to eventually be widely employed
and automated, providing sufﬁcient spatiotemporal resolution so that
the dynamics of populationmovement could be mapped and displayed
in real time. Population movements (both transient and permanent)
occur in different time frames, ranging from seasonal (e.g., vacations
and seasonal-driven migration) to daily (commuting to work, business
trips, errands, socializing, visits). The concept could revolutionize the
way that population data are visualized— in a way analogous to the im-
plementation of surveillance radar for actively conveying current
weather; on-the-ﬂy prediction capabilities from examination of trends
might also be possible. Moreover, the concept imposes no concerns re-
garding conﬁdentiality or privacy since the data never relate to identiﬁ-
able individuals.
The concept proposed here is based on the mining of the chemical
information contained in sewage. A portion of this untapped, rich
source of information resides in the numerous biomarkers of endogenous
human biochemical processes. These biomarkers continually undergo
urinary or fecal excretion and represent the sum total contributions
from the real-time population served by any given sewerage system.
The basis of the concept is the measurement of one or more biomarkers
whose intra- and inter-individual variation in daily per capita excreted
quantities is minimal.
The general approach is termed “analysis of small-area popula-
tions by sewage chemical-information mining” (ASAP-SCIM). This
paper outlines the general conceptual approach and discusses the
criteria for selection of suitable biomarkers whose levels in sewage
reﬂect per capita contributions and can therefore serve as proxies
for population counts.
2. Background
Beyond the numerous conventional uses of population estimates,
newly emerging applications relevant to measuring interactions at
the human-environment interface will require increasingly accurate
real-time, de facto population estimates — those capable of resolving
the diurnal ebb and ﬂow of small-area populations, such as the daily
redistribution from residences to locations outside the deﬁned area.
The most common of these newer applications are models aimed at
providing normalized per capita estimates of material ﬂows [e.g.,“pollutant load per capita” (Tsuzuki, 2006)]; examples include esti-
mating per capita contributions to the environment of pesticides, bio-
cides, drugs, personal care products, nanomaterials, and household
chemicals. These models facilitate better understanding of individual
contributions to waste streams, thereby permitting assessment of the
effectiveness ofmeasures targeted atwaste reduction, orwith assessing
environmental justice. Examples of the problems encountered and the
many variables and factors involved with deriving per capita ﬂows
can be seen in a number of papers (e.g., Khan and Nicell, 2010; Ort
et al., 2010a,2010b; Rieckermann et al., 2011).
In general, most of these current applications that make use of
chemical loadings in sewage must rely on inaccurate population
data derived from aged or incomplete sources such as census surveys
or utility customers billed (e.g., Anderson et al., 2004; Banta-Green
et al., 2009; Clara et al., 2011; Kasprzyk-Hordern et al., 2009; Neset
et al., 2010; Ort et al., 2009; Rowsell et al., 2010; Tsuzuki, 2006).
2.1. Prior approaches for using sewage to estimate population size
Advancements in estimating de facto small-area population size
would greatly aid the development of human-environment interface
models such as those for material ﬂows. One of the only attempts at de-
veloping a non-census based approach for estimating population was
conceptualized in the early 1970s. The model attempted to estimate
population size simply from an algorithm that used wastewater ﬂow
rates. “Demoﬂush” (a term derived from “demographics” and “ﬂush”)
was developed for Ocean City, Maryland, to gauge the annual inﬂux of
tourists, initially in order to plan for augmented stafﬁng ofmedical facil-
ities (Goldschmidt and Dahl, 1976); estimates using conventional tech-
niqueswere providing estimates of tourist inﬂux that varied by ﬁve fold.
Although simple in concept, the Demoﬂush model had to rely on
many unveriﬁable assumptions, a key one being the daily per capita
water usage — a value that is subject to many drivers. Confounding
its usefulness were additional unknowns such as sewer inﬁltration/
exﬁltration and contributions from industrial water discharge. A
very large but indeterminate error associated with the Demoﬂush
approach eventually became evident (Editorial, 2009; Russo, 2009)
and indicated that wastewater ﬂow cannot be used as a proxy for
population. There are too many variables and unknowns, all of
which will vary from city to city and depend on variations in local
conditions, sewerage infrastructure, periodic changes such as
season/weather, and local water usage customs and restrictions. The
information content of the physical attributes of sewage is insufﬁcient
for estimating population size.
Some material-ﬂow models have tried to make use of approaches
conventionally used for estimating population size for the design of
sewage treatment plants (STPs). Several terms are used in referring
to the population serviced by a particular STP: “population served,”
“population equivalent,” and “effective population.” Population
served refers to the population residing and paying hook-up fees
within the sewage district physically connected to a particular STP.
The population served approximates the de jure population. This
slice of population does not account for reduction or increase in
waste discharge that occurs during resident travel outside the STP's
service zone or for non-residents traveling into the zone. Population
equivalent (unit per capita loading) is an approach long-used for
roughly estimating the serviced population — a statistic relied upon
for design of STP capacity. It is based on the assumption that the
5-day biological oxygen demand (BOD5) of the material excreted
from one individual ranges from about 40 to 80g/day (Heidrich
et al., 2010); variations of this approach use BOD measured over dif-
ferent periods or similar measures such as chemical oxygen demand
(COD, which ranges from 60 to 120 g/day). A major problem with
the routine use of BOD is the time required for the test; this could po-
tentially be solved with new, real-time sensors (e.g., Hur et al., 2010).
But with respect to any potential utility for SCIM, BOD does not
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sures any biodegradable substance that enters sewers, which often
includes food waste and industry efﬂuents. The effective population
simply tries to account for all of those entities contributing BOD to
an STP's sewerage, whether originating directly from humans or
from other sources. Improvements based on these approaches have
tried to incorporate geographic information system techniques or
the use of conservative tracers such as boron (but whose presence
is not unique to human activity nor is its per capita usage stable)
(e.g., Fox et al., 2002; Keller et al., 2006, 2007).
A major confounder to basing population estimates on informa-
tion mined from centralized sewage systems is the incidence of the
resident population that is not hooked up to a system, such as those
using septic systems or even the less common practice of straight-
piping. The incidence of septic systems can vary greatly with locale.
On average, an estimated 20% of total U.S. housing units were served
by septic systems in 2007 (USEPA, 2008); the geographic distribution
is roughly equal among the rural and suburban US.
The need for accurate measures of a population whose combined
sewer discharge comprises the total ﬂow into a single STP was
catalyzed with introduction in 2001 (Daughton, 2001) of a material-
ﬂowmodel concept later to be termed FEUDS— “Forensic Epidemiology
Using Drugs in Sewage” (Daughton, 2011). The objective of FEUDS is to
use the measured concentrations of particular drugs (or metabolites)
excreted into sewage to back-calculate the original total usage and per
capita usage levels of the aggregate population; the FEUDS approach
is being extended to other substances, such as ethanol (Reid et al.,
2011). The overall usage data are normalized against the presumed
total population for the purposes of time-course or inter-population
comparisons of community-wide or per capita drug usage.
Since population size is not accurately known, as an alternative to
normalizing material-ﬂow data to the estimated population size, the
FEUDS concept as originally proposed (Daughton, 2001) suggested
that speciﬁc biomarkers might be used as surrogate population mea-
sures against which to normalize total usage. This could then indirectly
generate average per capita consumption rates. At that time, two of the
suggested biomarkers (Daughton, 2001) were creatinine (a major uri-
nary metabolite) and coprostanol (a major fecal sterol) (see Fig. 1).
These biomarkers will serve as the primary focus of the remainder of
this paper, although the prospects for several other biomarker possibil-
ities will be brieﬂy discussed.
3. Possible biomarkers for estimating population size via Sewage
Chemical-Information Mining (SCIM)
A large expanse of literature from a broad spectrum of disciplines
was examined in evaluating the potential utility of excreted biomarkers.
Publications were located using SciVerse ScienceDirect and Google
Scholar, coupled with locating numerous additional references byFig. 1. Chemical structures of select biomarkers.reverse and forward citation analysis. Full-text reprints were archived
in a bibliographic citation database (EndNote, Thomson Reuters), facil-
itating full-text keyword Boolean searches.
The many factors or attributes that need to be examined in deter-
mining whether a biomarker might be useful for estimating human
population size via SCIM are summarized in Table 1. An essential
characteristic for a biomarker to be useful for measuring population
is a low population-wide variance in the per capita absolute quanti-
ties excreted daily; knowledge of quantities excreted daily ensures
that diurnal variations (e.g., resulting from biorhythms) are fully
accommodated. Published data for daily excreted quantities of bio-
markers, however, are not provided as frequently as excreted concen-
trations. This is because most biomarker data come from clinical
studies, where sampling of subjects usually employs the spot testing
of excreta (convenience samples) rather than the much more onerous
collection of complete 24-h samples. Therefore, much of the published
data on biomarker excretion is reported in terms of concentration levels
in spot samples of either urine or feces. To derive the per capita daily ex-
creted rates from the concentration levels in spot samples of urine or
fecal material, the rates of elimination of urine (e.g., volume/day) or
fecal material (wet or dry mass/day) must be known for each study;
these data are often not provided by published studies, limiting the use-
fulness of the data.
3.1. Creatinine as a possible biomarker for estimating population
A reasonable starting point for selecting possible SCIMbiomarkers is
the published literature from clinical chemistry. A biomarker widely
used in clinical chemistry, and onewith extensive published data on ex-
cretion, is creatinine. A small portion of creatine (and phosphocreatine),
which is stored predominately in skeletal muscle, is continually con-
verted by non-enzymatic dehydration/cyclization to form the endoge-
nous anhydride, creatinine (a nitrogenous waste product cleared via
the kidney); the rate of conversion, in males for example, is about
1.6–1.7% per day (Boeniger et al., 1993).
Some historical context is required to understand the important
role played by creatinine in clinical chemistry. In 1905, Folin ﬁrst pro-
posed that urinary creatinine could be used to normalize (adjust) for
urine dilution in spot samples, in order to avoid collection of 24-h
samples (Edwards et al., 1969). For decades, levels of creatinine in
spot urine samples have been routinely used to normalize the levels
of other clinical urinary markers. Widely accepted has been the
assumption that creatinine is excreted at a constant rate, independent
of urine ﬂow/volume (and could serve as a measure of glomerular
ﬁltration rate). It could therefore be used to account for the relative
dilution of the urine sample (which is largely a function of hydration
status) or variation in diuresis (as a function of disease); urinary
creatinine concentration is therefore assumed to vary inversely and
in a constant manner with respect to urine dilution. Evidence con-
tinues to emerge, however, that creatinine may often serve as a bio-
logical marker of exposure or effect; one example is its variable
output being a strong function of arsenic methylation (Basu et al.,
2011). The many factors involved with variability in creatinine output
have been summarized by Ryan et al. (2011).
Considerable research has examined the intra- and inter-individual
excretion of creatinine in terms of urinary concentrations. For the
purposes of using SCIM to estimate population size, however, the ques-
tion is not whether creatinine excretion varies with respect to its
urinary concentration (which is expected), but rather, whether its 24-h
per capita mass output is constant — and therefore whether it can
serve as a measure of combined contributions from discrete individuals.
Important to note, however, is that only a small portion of the creatinine
excretion literature provides data on the basis of quantity excreted per
day; most is expressed in terms of concentration.
Although creatinine has been long used in clinical chemistry to
account for variations in urine output, the underlying principles are
Table 1
Ideal attributes for SCIM biomarkers targeted for estimating population.
Attribute Example Potential problem
Must be excreted into sewage Excretion via urine rather than feces poses
fewer sampling and analytical challenges
Excretion via feces creates a non-homogenous
sample stream and requires more comprehen
sive sample preparation
Uniqueness to human metabolism Coprostanol (CoP) is produced in signiﬁcant
quantities primarily by higher vertebrates that
synthesize cholesterol
Input possible from other animals where
industrial/agricultural sewage is mixed with
human sewage or runoff carrying animal feces
into combined sewers (both would serve to
confound data)
Exogenous sources are minimal Low occurrence in raw or cooked foods Creatinine occurs in meats and can be created
from creatine during cooking (can confound
data)
Minimal intra-individual variance in daily excretion Daily levels excreted by an individual vary
minimally over time
Stress or disease can affect the excretion of all
biomarkers
Minimal inter-individual variance in daily excretion Per capita daily excretion across a population
varies minimally
A wide spectrum of physiological variables can
dictate the excretion of biomarkers
(age, gender, genetics, stress)
Daily per capita excretion in sewage is independent
of extraneous variables
Minimal effect from season, weather,
geographic locale, water-use restrictions,
medication usage, diet
Diet can inﬂuence excretion variance for both
creatinine and CoP
Occurrence levels independent of design and usage
of sewerage system
Length of sewerage distribution pipes and
residence time of sewage in pipes
Time-dependent degradation by
microorganisms during sewage transit can lead
to variable reductions in biomarker levels
Minimal degradation of biomarker in ﬂowing sewage
(levels persist in sewage)
Slow degradation allows sampling raw sewage
further downstream, permitting better mixing
of inﬂuent “pulses”; ensures minimal loses
during transit through sewer connections of
varied lengths and residence times
Sewage pulses with widely varying biomarker
levels (compounded by changing pulse
frequency) greatly increase the required
frequency of sampling a
Levels in raw sewage well above method detection limit (MDL) Few analytical interferences; easier
implementation of a routine method
Isobaric biomarker isomers often become
common interferences with methods using
mass spectrometry
Minimal potential for exogenous interference from other sources Exogenous sources include residues of target
analyte on analyst's hands
Residues of target analytes can sometimes be
excreted as sweat (e.g., drugs) or remain from
prior dermal contact or direct application (e.g.,
personal care products) (Daughton and Ruhoy,
2009)
Homogenous distribution; biomarker preferably partitions to
aqueous phase
Minimal partitioning to dissolved or suspended
solids or sludge
Partitioning to solids increases the complexity
of sampling and sample preparation
Minimal degradation of analyte in sampled sewage
(levels persist in sewage)
Refractory to microbial degradation or to
further physicochemical degradation during
sample shipment or storage
Preservatives may be required to inhibit
microbial degradation in stored or shipped
samples
Minimal de novo, ex vivo formation of analyte in sewage Minimal formation by microbial activity during
sewage transit and during sewage treatment
Sampling of raw sewage as early as possible in
inﬂuent stream may be necessary
Minimal sample clean-up and sample preparation Requires minimal pre-concentration to meet
MDL
Excretion of biomarker in the form of
conjugates may require additional hydrolysis
step
Analytical determination uses instrumentation
routinely available; analytical methodology amenable to standardization
Conventional GS/MS, LC/MS, or immunoassay Innovative “research grade” methodologies are
too costly or complex for wide implementation
Minimal capital investment in instrumentation; minimal analyst time Allows for high-frequency sampling “Research grade” methodologies are too costly
for wide implementation
High sample through-put Amenable to automation; reduces cost Analyst intervention reduces timeliness of
results
Potential for in-stream continuous sampling or monitoring Equilibrium passive samplers (EPS) allow for
passive, time-integrated sampling;b in-stream
sensors facilitate real-time data
Discrete sampling gives biased results because of
stream heterogeneity and sewage pulses
Minimal occupational hazards for technicians Minimal hazards from samples, and from
analytical reagents or reactions
Handling raw sewage poses risks associated
with pathogen exposure
a The challenges associated with obtaining representative samples from an STP are discussed by Ort et al. (2010b).
b Examples of EPS (Zabiegała et al., 2010) include polar organic chemical integrative samplers (POCIS) and semipermeable membrane devices (SPMD).
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that derive from numerous variables. Despite its wide acceptance in
clinical chemistry, the published literature (even as far back as the
1950s) shows that intra- and inter-day creatinine excretion is not
constant and that daily excreted quantities can have high variance.
As one example, a wide range (nearly 3-fold) of creatinine output
among individuals was shown in a 1968 study, where mean daily
creatinine output over the course of several weeks among four men
in apparently good health ranged from 914 to 2552 mg/day (Scott
and Hurley, 1968).
About 60 references with creatinine excretion data, spanning the
years 1968–2011, were examined for the work reported here.Numerous studies have shown that daily urinary creatinine excretion
can vary widely for individuals and even more among a population. A
few of these are summarized here. A review of the literature
(1905–1970) on the variability of creatinine daily excretion revealed a
coefﬁcient of variation of intra-individual daily excretion rates ranging
from about 3 to 20% in different subjects (Curtis and Fogel, 1970). In
children, 24-h excreted creatinine can vary by more than an order of
magnitude among individuals. For example, in boys with heights span-
ning 2-fold (90–196 cm), creatinine excretion was found to range over
an order of magnitude — from 1.3 to 17.8 mmol/day (Remer et al.,
2002). In a study of 8 subjects over 6–10 months, mean daily excretion
ranged from 1.54 to 1.87 g/day, and the range of the individual values
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spanned 1.01 to 2.58 g/day (Greenblatt et al., 1976); variance was
later shown to derive largely from seasonal inﬂuences (Ransil et al.,
1977). In a study that collected single 24-h urine samples, levels of cre-
atine were 1.325±0.525 μg/day for 32 smokers and 1.459±0.470 μg/
day for non-smokers; levels were roughly 70–80% higher for males
than females (Yan et al., 2007).
One study on reference ranges for creatinine in urine used 288 vol-
unteers across six age groups (spanning ages from birth to over 70)
from both genders (Weykamp et al., 1989). For the age groups from
17 to over 70, creatinine excretion ranged from 4.1 to 19.4 mmol/day.
For the age groups from 0 to 16, the creatinine levels ranged from 0.5
to 15.3 mmol/day. Urinary creatinine from 254 working adults was
measured yearly for up to 9 years in a study involving 1217 samples
of 24-h collections (one per year) (James et al., 1988). Daily urinary
creatinine excretion (mg/day) for all women was 1041±291, com-
pared with all men at 1642±418. Depending on body weight, the
range of daily individual excretion over a period of 5–9 years spanned
the extremes of roughly 400–600 mg/day (for white women) to
2000–3200 mg/day (for black men)— roughly a 5-fold range. Variabil-
ity for individualswas about 15%.Men excreted about 33%more per day
than women. It is important to note that the variance may have been
even higher, as outliers were excluded under the possibly erroneous
assumption that they resulted from 24-h sample collections that were
incomplete; this is a problem that confounds the examination of popu-
lation variance in many creatinine studies using 24-h collections, as
exclusion of outliers was often based partly on the circular assumption
that creatinine excretion was supposed to be constant.
A study of 24-h urine samples from 2075 men and 1933 women
showed creatinine daily levels (mmo1/24 h) of 14.36±4.1 for men
and 10.28±2.7 for women; levels from men were on average 40%
higher than women (Kesteloot and Joossens, 1996). This study, like
others, showed a continual diminution in excretion with age —
decreasing in men (and women) from a maximum of 15.69 (11.04)
mmol/day for 35–39 years old to 12.27 (8.86)mmol/day for 70 years
and older. Broad and skewed distributions for daily output of creati-
nine are a function of gender, presumably because of the differences
in skeletal muscle mass. Excretion was observed to vary across the
range of 1–2.5 g/day, with tails below 1 and up to 3 or more grams
per day. The most frequent values for males were 1.5−2.0 and for
females 1.0−1.5 g/day. Day-to-day intra-individual daily ranges (over
4 consecutive days) spanned 9−79% of the maximum values, with
the total range among all individuals spanning roughly 0.5−2.4 g/day
(Alessio et al., 1985). In 20 healthy subjects, 24-h urinary creatinine
averaged 1638mg/day with a 3-fold range of 1114−3697 mg/day
(Newman et al., 2000). In 21 normal adult males and females, urinary
creatinine ranged from 910 to 2212 mg/day (Forbes and Bruining,
1976). In the same study, with 13 younger males and females but with
“short stature”, creatinine ranged from 184 to 956 mg/day; variance
over at least three consecutive samplings for each individual ranged up
to 19.5%.
Since creatinine is produced in skeletal muscle, it should not be sur-
prising that its daily excretion varies so much across a random popula-
tion. Indeed, creatinine excretion can beused as a good estimate for lean
or skeletal muscle mass (Forbes and Bruining, 1976;Wang et al., 1996).
Urinary creatinine excretion is also highly inﬂuenced by diet com-
position. In one of the ﬁrst metabolically controlled studies, consump-
tion of protein/creatine-rich foods was found to affect creatinine
excretion by roughly 50% (23.4 mg/kg/day versus 15.7 mg/kg/day)
(Bleiler and Schedl, 1962). The increased excretion of creatinine (up
to 33%) after consuming meat has been extensively documented
(e.g., Bingham and Cummings, 1985; Hoogwerf et al., 1986;
Kesteloot and Joossens, 1993; Mayersohn et al., 1983; Neubert and
Remer, 1998). The growing popularity of creatine as a food and nutri-
tional supplement adds yet another source of potential variation to
excretion rates.This is but a small sampling of studies that demonstrate high
variability in daily creatinine excretion. Such high variation should not
be surprising given that creatinine excretion is modulated by
numerous endogenous and external factors. Excretion is a complex
function of diet and food preparation (which serve as exogenous
sources of creatine and creatinine), muscle mass (a factor in differences
between genders [higher in males] and age [declining with advancing
age], as creatine is stored in skeletalmuscle), energy expenditure (exer-
cise and activity level), hydration and temperature, and health status
(e.g., kidney dysfunction or pathologies). In subjects with a range of
kidney diseases, creatinine output can easily span an order of magni-
tude and more; multi-fold changes can occur over a period of several
days for individual patients (Waikar et al., 2010). Wide variance in
creatinine excretion has been documented for a number of other dis-
eases as well, including cystic ﬁbrosis (Wagner et al., 2010).
Themany and complex factors that affect creatinine formation and
excretion and which contribute to extensive variability (including exer-
cise) are discussed in numerous studies (e.g., Barr et al., 2004; Boeniger
et al., 1993; Calles-Escandon et al., 1984; Hee, 2010; Heymsﬁeld et al.,
1983; Suwazono et al., 2005; Worsfold et al., 1999; Wyss and
Kaddurah-Daouk, 2000). Since the body's creatine/phosphocreatine
pool is large (about 120 g for a 70-kgman), small variations in its conver-
sion to creatinine can lead to multi-fold variability in intra- and inter-
individual daily excretion; roughly 2 g/day of creatine are converted to
creatinine.
3.1.1. Confounding of SCIM data by creatine/creatinine in foods
An aspect of creatinine important to its potential for use in this
proposed SCIM application is not discussed in the clinical chemistry
literature, as it is not relevant to clinical science. Creatinine does not
have an exclusive endogenous origin. It also occurs in, or originates
from, foods. This could greatly confound interpretation of its presence
in sewage. A portion of excreted creatinine is derived directly from
exogenous dietary intake. Creatine, and proportionately lower levels
of creatinine, occur in certain foods (especially muscle tissues). Heating
and cooking serve to convert signiﬁcant portions of creatine to creati-
nine. Creatinine is not absorbed from the gut, and dietary intake
would therefore pass into the feces. Furthermore, the disposal of left-
over prepared foods directly to sewers undoubtedly serves as a source
of creatinine of unknown magnitude and one that would have a highly
variable correlation with per capita origins. These sources of creatinine
would confound interpretation of its levels in sewage for use in SCIM
applications.
The exogenous formation of creatinine in foods is shown by the heat
treatment of rawmilk for the purposes of pasteurization or sterilization.
Heating can catalyze extensive conversion of creatine to creatinine, with
conversion increasing in direct correlation with temperature and dura-
tion of heating. The molar ratio of creatine/creatinine decreased from
about 8 (in raw milk) to 2.3 (in sterilized milk). It was estimated that
daily per capita consumption of 500 mL of sterilized versus raw milk
would increase creatinine daily excretion by 7 mg (Manz et al., 1991).
The levels of creatinine in ﬁve pre-cooked meat products ranged
from 8.2 to 15.1% of the total creatine levels (which ranged from
about 1 to 4 mg/g cooked meat); total levels of creatinine ranged up
to about 0.7 mg/g, for cooked ham. Creatine levels were linearly related
to total protein content (del Campo et al., 1998). Substantial levels of
creatinine exist in many raw meats, and levels increase multi-fold
upon cooking (up to nearly 200 mg/100 g dry, fat-free tissue) as a
result of dehydration of creatine (Macy et al., 1970).
3.1.2. Creatinine in sewage
The use of creatinine in sewage as a parameter against which to
normalize for obtaining per capita contributions of other excreted
chemicals was ﬁrst proposed in 2001 — for the purposes of illicit
drug monitoring (Daughton, 2001, 2011). The ﬁrst attempt at imple-
menting this particular use in sewage was in 2008 (Chiaia et al., 2008;
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sewage are rare. In the work of Chiaia et al. (2008), its levels in
sewage from seven STPs were found to range from 220 to 1500 μg/
L, translating in these cases to a range in estimated per capita rates
of 120 to 620 mg/day. Such wide variance is consistent with the
data previously summarized (Section 3.1) from some of the many
studies on creatinine excretion. Only a few prior studies exist where
creatinine was measured in sewage. One of the ﬁrst was Alexander
and Stevens (1976). Another study measured creatinine in STP inﬂuent
using two different techniques, yielding values of 311 and 121 μg/L, but
several analytical problems were noted regarding its determination in
wastewaters (Bisceglia et al., 2010).
3.2. Coprostanol (CoP) as a possible biomarker for estimating population
We have seen that even though creatinine is a urinary biomarker
noted in clinical chemistry for its purported exceptionally stable
excretion rate, its daily variance in quantity excreted is probably too
large to serve as a potential surrogate measure for per capita popula-
tion contributions to sewage. Its excretion is a function of many
variables, each having considerable variance among the general
population. A reasonable conclusion might be that other possible bio-
markers would have even greater variance since creatinine is used so
widely in clinical chemistry solely because of its comparatively stable
excretion rate.
One biomarker, however, has distinctly different physiological ori-
gins. Some of the sterol metabolites of cholesterol originate not from
human biochemical pathways, but rather from microbial metabolism
in the gut. Published data indicate that the production of at least one
of these sterol metabolites – coprostanol – might have a multi-modal
inter-individual distribution, but variance in its intra-individual produc-
tion rate is comparatively low and stable with time [e.g., daily variation
less than 5% (de Leon et al., 1987)].
Of the 512 possible stereoisomers of reduced cholesterol, only
two occur widely in nature — cholestanol and coprostanol (Walker
et al., 1982). Coprostanol (5β-cholestan-3β-ol; CAS RN 360-68-9;
MW=388.67) is a 5β-stanol and differs from cholesterol only by
saturation of the C5–6 double bond (see Fig. 1); in the older litera-
ture it is sometimes referred to as coprosterol. Coprostanol (CoP) is
the preponderant 5β-stanol in human feces, comprising roughly
60% of the overall sterol content, although this percentage can vary
widely among individuals. A fully saturated microbial metabolite of
cholesterol, CoP is poorly absorbed from the gut (it does not undergo
enterohepatic circulation) and is therefore fully excreted in the
feces; this is believed to serve as a mechanism for lowering serum
cholesterol levels.
Given the large published literature on CoP, there have been few
comprehensive reviews. One of these was published 30 years ago
(Walker et al., 1982). Another review on the general topic of bio-
markers compiled much of the pre-1998 published data on CoP oc-
currence in feces, wastewater, and sludge (Takada and Eganhouse,
1998).
The published literature surrounding coprostanol is extremely
large and cannot be comprehensively summarized. For the work
reported here, over 200 papers published between 1934 and 2011
having data related to concentrations in sewage or in urine or feces,
or to excretion rates, were examined; the most relevant data from
only a portion of these were mined. This literature spans a number
of non-intersecting ﬁelds, a result of CoP being studied in the ﬁelds
of medicine and clinical science, microbiology, geochemistry, nutri-
tion, agronomy, archeology (e.g., Birk et al., 2011; Bull et al., 2003;
Evershed and Bethell, 1996), analytical chemistry, and environmental
science, among others. Most of this literature is not relevant to the
proposed use of CoP for SCIM. The only relevant aspects are the vari-
ables that inﬂuence the synthesis and excretion of CoP in the human
gut and the overall levels of CoP in excrement (fecal material) and inraw (unsettled) sewage. Interest in the topic of CoP in fecal material
declined prior to 2000, while interest in the use of CoP for source
tracking for sewage has increased since 2000.
CoP has a long history of use as a marker of sewage contamination
(Hatcher and McGillivary, 1979), especially in sediments (e.g., Pratt
et al., 2007) and surface waters (Tabak and Bunch, 1970). In contrast,
its analysis in raw and treated sewage has been comparatively infre-
quent, primarily because such data had no apparent use. One of the
earliest studies to propose the use of CoP in environmental monitoring
was Murtaugh and Bunch (1967). Early work by the US Environmental
Protection Agency pioneered the use of CoP as an indicator of ambient
water contamination by sewage (Tabak et al., 1972). In the 1970s, CoP
was ﬁrst proposed for use in an index for contamination of sediments
by sewage (Goodfellow et al., 1977).
Environmental monitoring studies have routinely detected CoP in
surface waters and especially sediments. Given its origins with fecal
material, and its presence at relatively high concentrations, it is
often used as a marker for the degree of fecal contamination in ambient
waters or as a surrogate measure for human bacterial levels in waters
(Leeming and Nichols, 1996). It can also be used to gauge the degree
of dilution of raw or treated sewage in receiving streams (Takada and
Eganhouse, 1998). CoP (together with other sterols) has been used as
amarker in sediment cores to performdetailed examinations of historic
contributions of sewage to marine systems (Venkatesan and Kaplan,
1990).
CoP is excreted by different vertebrates in differing absolute and
relative quantities. By monitoring for various associated co-
metabolites (such as other stanols), ratio indices can be used for source
tracking or for distinguishing between contamination from humans
versus wildlife or domestic animals (Bull et al., 2002). Sterols have
also found use as markers for detecting fecal contamination of
urine in waste handling systems designed to separate urine prior to
waste treatment (Börjesson et al., 1998; Höglund, 2001; Schönning
et al., 2002).
3.2.1. Biological origins of CoP
Clinical research has been the driver for much of the research on
the biosynthesis of CoP in humans. A major question motivating
most of this work has been whether bacterial metabolism of choles-
terol in the colon is associated with a variety of diseased states — as
both a marker and as a causative or protective factor (Lichtenstein,
1990).
Some of the ﬁrst experimental evidence that CoP is formed from
the hydrogenation of cholesterol by speciﬁc bacterial action in the
human gut was published in 1934 (Dam, 1934). While CoP is the pre-
dominant reduced sterol formed in the human gut, it can also be pro-
duced in substantial quantities (mg/g wet fecal mass) by other
vertebrates, such as pigs, cows, horses, rabbits, and limited avian spe-
cies (e.g., chickens) — but usually not as the dominant sterol (a major
distinguishing factor from humans) (Leeming et al., 1996; Shah et al.,
2007; Tyagi et al., 2008); CoP has been identiﬁed, however, as the
dominant sterol in swine slurry (Jaffrezic et al., 2011). Worth noting
is that animal inputs to combined sewers could serve as confounders
in the interpretation of ASAP-SCIM data based on CoP.
3.2.2. Gut microbiome composition as the primary driver in human
coprostanol production (converters versus non-converters)
CoP production by the human gut microbiome is characterized by a
particular attribute that impacts its utility as a biomarker of per capita
population. While the daily variation in intra-individual production is
comparatively low, the efﬁciency with which it is converted from cho-
lesterol seems to depend on the species composition of the microbial
consortia in the gut. Evidence indicates that the efﬁciency of its produc-
tion (conversion) does not span a continuum, but rather displays two to
three discrete intervals of conversion efﬁciency— often loosely catego-
rized in the literature as nil, low, and high. Signiﬁcantly, these categories
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term rate of production across a given population is not altered.
The fact that the efﬁciency of inter-individual cholesterol metabo-
lism (from nil to high) is distributed across two or three distinct sub-
populations is consistent with the growing evidence for the existence
of gut microbiomes of distinct and stable community compositions —
referred to as “enterotypes”. A recent study reveals that the gut
microbiome is dominated by abundant species from two phyla –
Firmicutes (e.g., Bacilli and Clostria) and Bacteroidetes (e.g., Bacter-
oides) – with numerous low-abundance species contributing to a
signiﬁcant long-tail distribution, which possibly contribute highly
specialized functions. Like CoP production, the possibility exists that
the compositions of gut microbiomes are not distributed over a con-
tinuum, but rather exist as discrete entities. Three enterotypes may
exist, each comprising deﬁned consortia of distinct, co-occurring
species. Moreover, these enterotypes, while differing in function,
appear to resist inﬂuence by any number of variables, including com-
position of diet (especially regarding the intake of phytosterols), nu-
tritional status, gender, age, nationality, or body mass index (BMI)
(Arumugam et al., 2011).
There is no evidence that CoP is produced by a few, particular bac-
terial species. Rather, it seems to result from the combined metabo-
lism of ill-deﬁned consortia whose populations must reach a critical
level. At least 106 cells/g fresh fecal material may be required, with
108 cells/g required for complete conversion of cholesterol to CoP.
Those individuals having too few coprostanoligenic bacteria are very
inefﬁcient converters and seem to comprise a small but signiﬁcant
percentage of at least some continental populations. Frequently
cited for the bi- or tri-modal population distributions is that roughly
20–25% of various populations studied are “non-converters,” where
CoP comprises less than a third of their total fecal neutral sterols
(Veiga et al., 2005).
Bacterial conversion seems to occur via two pathways — direct
(from cholesterol) and indirect (via coprostanone as an intermediate)
(Gérard, 2010; Gérard et al., 2007). Although esteriﬁed CoP conju-
gates can also be formed, the evidence is conﬂicted as to whether
they compose a signiﬁcant portion of CoP. Regardless, it is believed
that they undergo facile hydrolysis and therefore a saponiﬁcation
step may not prove to be important in analysis of sewage for total
CoP (Kirchmer, 1971; Rosenfeld, 1964; Rosenfeld and Hellman,
1971).
3.2.3. Inter- and intra-individual variation in cholesterol-CoP conversion
Variation in CoP excretion within and between individuals com-
prises two aspects. One involves the multi-modal inter-individual
distribution of CoP microbial production from cholesterol — loosely
referred to as low- and high-conversion, with an extreme of non-
conversion; the distribution of conversion efﬁciency among a popula-
tion seems to be a function in part of age and gender and is driven by
the composition of the gut microbiome (Benno et al., 2005). The
second involves the intra-individual daily variation (or constancy)
in CoP excretion.
The ﬁrst major study of the bi-modal distribution of population-
wide conversion efﬁciency for CoP was Wilkins and Hackman
(1974). The high- and low-conversion traits (an arbitrary cut-off for
the two groups was deﬁned at the 50% conversion level) were stable
over long periods of time (at least up to 22 months), but isolated,
transient instances occurred when a high- or low-converter inverted;
sporadic inversion between low and high conversion has also been
noted after cessation of antibiotic therapy (Midtvedt et al., 1990).
The range of conversion efﬁciencies, while not a continuum, can
span from nil to 99%. In a test group of 31 North American adults,
there were 23 high-converters, with CoP levels of 21.3±8.6 mg/g
dry feces (CoP composing 61% of total steroids). In the remaining
eight low-converters, CoP levels were 4.1±4.3 mg/g dry feces (8%
of total steroids). The low-converters represented roughly 25% ofthis small limited test population (Wilkins and Hackman, 1974).
The incidence of low-converters in North America is often given as
20–25%, but this is a rather rough approximation. The bimodal distri-
bution of high- and low-converters has been recently discussed by
Keller (2010).
Establishment of the gut bacteria responsible for conversion be-
gins about 6 months after birth in those who become converters; con-
version efﬁciency then increases into the late teens (de Leon et al.,
1987; Midtvedt and Midtvedt, 1993). The factor that consistently
reduces CoP production the most (for unknown reasons) is probably
age; note that urinary creatinine also declines with age, but for a
different reason (i.e., loss of skeletal muscle mass). For the purposes
of the ASAP-SCIM concept, age corrections could possibly be derived
from existing demographics already in use for existing population
modeling.
The percentage conversion of cholesterol to CoP across four coun-
tries (France, Germany, Italy, and Sweden) ranged from 55 to 76% in
males and 40–66% in females (in a study involving 94 subjects)
(Norin, 2008); an additional 13 subjects (12% of the total subjects)
were non-converters. The range among elderly was 61–74%. The
“normal” level of CoP conversion in feces may vary geographically.
Diet, drugs, and other interventions that reduce cholesterol (or
alter the gut microbiome, such as antibiotics) can also result in
changes in coprostanol levels formed and excreted (Benno et al.,
2005; Keller et al., 2008; Korpela and Adlercreutz, 1985; Midtvedt and
Frederichsen, 1977; Midtvedt et al., 1990; Norin, 2008). Antibiotics in
particular tend to lead to reduced conversion to CoP, usually after treat-
ment with those targeting anaerobic, Gram-positive bacteria rather
than those targeting aerobic, Gram-negative bacteria (Midtvedt et al.,
1990).
3.2.4. Per capita total daily excretion of CoP
The published literature on the human excretion of CoP and other
sterols is extensive. Most of this literature comprises clinical or
epidemiological studies examining correlations with diet or disease,
especially colonic cancers. For a short review, see Nair (1988). Unfor-
tunately, the data from these many studies is reported on the basis of
a disparate spectrum of approaches making intercomparisons very
difﬁcult. For example, CoP levels are most frequently reported as
concentrations (presented on the basis of mass per unit mass, or
mass per unit volume) in fecal water, fecal wet mass, or fecal dry
mass (e.g., Glatz et al., 1985; Keller and Jahreis, 2004; Lipkin et al.,
1981; Shah et al., 2007).
Much less frequent are data presented in terms of total daily
excreted mass. The only basis having direct relevance to the concept
proposed here is the per capita ﬂux in terms of total excreted daily
quantity (mass or moles). Data are usually reported in terms of fecal
concentrations because studies are often designed to test whether
CoP levels correlate with diseases of the colon. But CoP concentrations
alone are not useful for evaluating the potential of the SCIM concept
unless the total daily excreted fecal mass is also known; even then,
sometimes the daily excreted amounts are normalized against body
mass (e.g., mg/day/kg body weight), but the body masses are not pro-
vided. This is because the daily excreted fecal mass excreted can vary
widely as a function of the individual and diet (a major determinant is
consumption of indigestible ﬁber); the fecal concentration of CoP is
often lower when the fecal mass eliminated increases.
Dietary factors that inﬂuence CoP fecal concentrations are com-
plex (Kay, 1981). Major factors are intake of meat (increases CoP con-
centrations) and ﬁber (reduces CoP concentrations). The difference in
extremes is often a factor of 2 (e.g., Jenkins et al., 1975; Korpela and
Adlercreutz, 1985; Reddy et al., 1975, 1998; Ullrich et al., 1981; van
Faassen et al., 1987; Weststrate et al., 1999).
Another major factor can be colon disease. For example, the fecal
CoP concentrations (mg/day/g dry fecal mass) for those with polyposis
of the colon and familial colon cancer are 20–50% those of healthy
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Reddy et al., 1976; Watne et al., 1976); the frequency of low-
converters is also much higher. Some data, however, are contradictory.
Two studies, for example, show colonic cancer correlating with fecal
CoP levels up to severalfold higher than healthy controls (Korpela
et al., 1988; Peuchant et al., 1987).
Most of the published data on per capita excretion rates for CoP
(usually expressed in mg/day) have been summarized in Table 2. Of
over the 200 studies examined (inclusive of studies published in
2011), only 13 (all published between 1964 and 2002) provided
daily CoP excretion rates or data from which rates could be easily de-
rived; as mentioned above, numerous other studies are available, but
they report only CoP fecal concentrations. A few provide data that can
be used to indirectly estimate per capita excretion rates. For example,
using sterol loadings in sewage inﬂuent for three STPs in France, one
study calculated estimated ﬂuxes of total sterols of 0.5–0.6 g/day/
capita (Quéméneur and Marty, 1994). CoP was reported to comprise
37–48% of particulate sterols and 13–34% of the dissolved sterols in
the inﬂuent sewage. Using these extremes, an estimated per capita
CoP ﬂux can be deduced as perhaps having a range of 65–288 mg/day.
In 1972, Tabak et al. (1972) stated that humans on average excrete
CoP at a rate of 800–1000 mg/day per person. Even though most of
the data on CoP excretion rates were published after 1972, this esti-
mate for a range for human excretion rate seems to rest within the
high end of the range of values reported in the studies published
since. The frequency of low-converters (including non-converters)
brings the average down.
A visual inspection of the CoP excretion data summarized in
Table 2 reveals that a range of 200–700 mg/day perhaps encompasses
the bulk of the published data. While the extremes of the total ranges
of daily CoP excretion rates from all of the studies combined is some-
what broad, a key point is that the range for any given study is much
narrower, especially if the data for low- and high-converters (when
reported) are averaged. This undoubtedly reﬂects differences in theTable 2
Selected data on per capita total daily excretion of CoP a.
Per capita CoP excretion rate Study size
270±62 mg/day 12 healthy adults
567±214 mg/day 6 healthy subjects
nil 8 subjects fed a high-carbohy
346±45 mg/day 38 healthy adults; none was
420 (301–662) [129–704]mg/day
bbutter-supplemented diet>
417 (228–666) [128–1305] mg/day
bcorn oil-supplemented diet>
Mean (and range) of individu
subjects
222–740 mg/dayb 22 subjects
500–1500 mg/day (total fecal neutral sterols)
[CoP rate would be roughly 40–80%]
Preponderance of data from 1
155.2–345.3 mg/day Range in averages for 5 patie
80.9±21.9 mg/day – 18 Seventh-Day Adventist p
150.4±21.2 mg/day – 50 SDA lacto-ovo vegetaria
152.9±24.1 mg/day – 50 SDA non-vegetarians
182.8±40.7 mg/day – 50 general population non-
266.4 mg/dayb 22 Indian vegetarians
634.5 mg/dayb 22 white omnivores
357.1 mg/dayb 18 white vegetarian premeno
3.65 mg/day/kg body weight – Existing mixed western die
7.24–7.45 mg/day/kg body weight (for a 70 kg individual,
these translate to 256 mg/day and 507–522 mg/day)
– High-fat, high-beef diet
30 subjects; excretion rate re
794–995 mg/day (5 subjects)c Two groups possibly displayi
(including conjugates)241–499 mg/day (2 subjects)
294–668 mg/day (7 subjects)c 10 subjects (7 healthy and 3
5–6 mg/day (2 subjects)
100 mg/day (1 subject)
a These data exclude all reports that provided CoP excretion data solely on the basis of f
b Ranges and averages of excretion rates derived from data in cited reference.
c Some studies, with multiple ranges, often provide data for sub-populations with diseasanalytical methodologies, as a wide variety of analytical methods
have been used in CoP excretion studies. Given the extremely broad
array of variables and analytical approaches used in these published
studies, the data are remarkably consistent. This contrasts with creat-
inine, whose excretion data has presumably beneﬁted from the use of
long-standardized clinical analytical methods.
3.2.5. Analysis for CoP
Analytical methodology (including the sampling process) probably
drives a considerable portion of uncertainty in CoP data. Despite the
broad targeting of CoP in numerous studies over the decades, there
has been no attempt at standardizing the analytical methodology —
especially for feces and sewage. The limit of detection is not an issue
given the high levels of CoP in sewage. Speed and sample throughput
are probably the limiting factors, as sample clean-up poses challenges.
Another challenge (a possible issue in sewage analysis but not in
analysis of human fecal material) is distinguishing CoP from epicopros-
tanol— its epimer 5β-cholestan-3α-ol (Eganhouse et al., 1988). Distin-
guishing CoP epimers, however, has since become a routine aspect of
analysis, especially in monitoring programs designed to distinguish
human fecal sources from contributions by wildlife (e.g., Hughes and
Thompson, 2004).
Improvements in various aspects of analysis have been published
over the years, including improved extraction (Moliner-Martinez et al.,
2010) and derivatization, for gas chromatographic separations (Wu
et al., 2010). For a given methodology, inter-sample and inter-analyst
precision can be high. For example, 10 subsamples from a 24-h com-
posite sample of STP inﬂuent in Italy were divided among two techni-
cians, yielding mean CoP levels of 34.3±1.7 μg/L and 33.4±2.2 μg/L
(Gilli et al., 2006).
For the purposes of the SCIM application presented here, a major
challenge would probably be development of methodology for
sampling and quantifying CoP in sewage solids (including suspended
particulates), as the hydrophobicity of CoP limits its solubility in theReference
Bartram et al. (1991)
Batta et al. (2002)
drate diet free of fat and ﬁber for 12 days DenBesten et al.
(1973)
a low-converter (all showed greater than 89% conversion) de Leon et al. (1987)
al averages, and [total range of individual values] for 6 Eneroth et al. (1964)
Férézou et al. (1978)
5 studies published from 1957 to 1965 Miettinen et al.
(1965)
nts on a constant fat diet monitored for 3 weeks Mitchell and Diver
(1967)
ure vegetarians Nair et al. (1984)
ns
vegetarians
Reddy et al. (1998)
pausal women
t Reddy et al. (1980)
turned to 3.84 mg/day/kg body weight post test diet
ng high and low conversion; data represent total CoP Rosenfeld (1964)
hospitalized) Sekimoto et al. (1983)
ecal concentrations with no indication of fecal mass excreted per day.
es or having high-, low-, and nil-conversion efﬁciencies.
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sewage-monitoring studies. This topic is discussed in Section 5 (The
challenge of representative sampling).
3.2.6. Stability of CoP
The stability of CoP (dictated primarily by its relative susceptibility
to biodegradation) has relevance with respect to how far down an
STP's process stream sampling can take place and what precautions
need to be addressed when storing or shipping samples. Because of
mixing, the homogeneity of STP inﬂuent increases further down-
stream, reducing the challenges for discrete sampling, but the impact
of biodegradation can rise.
Oxygen partial pressure plays an important role in the biodegrada-
tion of CoP. Microbial degradation proceeds faster under lower oxygen
tensions but is inhibited in anoxic conditions. The highest average rate
of biodegradation (0.438 μg/g/day) was found to occur in sediment
fromnon-aerated coastalwater (Bachtiar et al., 2004). AlthoughCoP ap-
pears to degrade exponentially in raw primary sewage sludge (Bartlett,
1987), it has shown stability for up to 118 days in urine with feces pre-
sent (Sundin et al., 1999). These data indicate that CoP would best be
sampled early in an STP inﬂuent stream.
3.2.7. CoP in raw sewage
Although the daily per capita excretion of CoP seems to have con-
siderably less intra- and inter-individual variance than the widely
used clinical urinary biomarker creatinine, its analytical determina-
tion in sewage may prove more challenging — primarily because of
its hydrophobicity. The log Kow for CoP is estimated at 6.3–7.6, and
its aqueous solubility is estimated at 0.7 μM (ca. 272 μg/L) (Takada
and Eganhouse, 1998). CoP is therefore expected to preferentially
partition to solids. Indeed, a signiﬁcant portion of the CoP that enters
an STP is eventually associated with sewage sludge; but since the
overall volume of sludge is small compared with the aqueous phase,
the levels of dissolved CoP could possibly provide an estimate of over-
all CoP loadings. Unless the particulates and suspended solids in raw
sewage are included during sample acquisition and analysis, only the
dissolved portion of CoP will be determined. As one example, CoP was
detected at roughly a level of only 10 μg/L in water decanted from a
solids separation step at an STP (Chaler et al., 2001).
Much of the published literature on the occurrence of CoP in sewage
therefore excludes an unknown portion of CoP. Some occurrence data,
however, indicate that CoP may be present at total levels closer to its
aqueous solubility, minimizing the portion sorbed to solids. Sometimes
the published data on CoP levels in sewagemay therefore be close to the
actual levels (i.e., when they are low). Otherwise, many of the
reported apparent levels of CoP dispersed in the aqueous phase of
sewage are probably due to CoP sorbed to dissolved organic material
or colloids.
Despite the limited aqueous solubility of CoP, the large absolute
quantities continually excreted into sewage make it one of the
major aqueous-phase organic constituents — exceeded only by the
heavily used surfactants (linear alkylbenzenesulfonates) and the che-
lator nitrilotriacetic acid (Nguyen et al., 1994). The absolute quantities
of CoP excreted by metropolitan regions can indeed be large, as
shown by the combined annual mass emission rate of coprostanol and
epicoprostanol from municipal wastewater treatment plants into the
southern California Bight (which includes coastal southern California)
— an estimated 260 mt/year, in 1987 (Venkatesan and Kaplan, 1990).
The limit of detection is therefore not an issuewith respect to analytical
methodology.
Homogeneity via adequate mixing is central to ensuring measure-
ment of representative CoP loadings in raw sewage. In one of many
similar studies, over 70% of CoP was shown to be associated with cen-
trifugable particulates. Ensuring adequate mixing is therefore impor-
tant. In ﬁve sub-samples of the same well-mixed raw sewage sample,
CoP values spanned the range of 200–270 μg/L (mean 228±31.14)(Switzer-Howse and Dutka, 1978). Other studies have collected sus-
pended particulates (e.g., by physical ﬁltration) and compared sol-
vent extracts with those of the ﬁltrates. One study, for example,
showed that over 95% of the sterols (including CoP) in sewage inﬂu-
ent and efﬂuent were associated with particulates (Isobe et al., 2002).
And another reported over 84% of CoP in treated sewage was associ-
ated with particulates (Brown andWade, 1984). Two samples of sew-
age sludge contained CoP at 1.96 and 3.3 mg/g suspended material
(or an equivalent of 41.16–25.08 mg/L) with only 0.22–0.34 mg/L dis-
solved (Takada et al., 1994). CoP was present in U.S. municipal sewage
sludges at 2.6–55 mg/L; the coefﬁcient of variation for replicate samples
ranged from 1 to 10% (Eganhouse et al., 1988). Its partitioning to sludge
(at part-per-million levels) (Takada and Eganhouse, 1998) explains
why CoP is apparently so easily removed during sewage treatment
(McCalley et al., 1981). Extensive data on the preferential partitioning
of CoP to particulates are available (e.g., LeBlanc et al., 1992).
Although numerous papers report on CoP levels in sewage, no
attempt has been made to summarize the data here because the
levels of CoP in sewage are useful for the SCIM concept only when
the ﬂux of CoP is known. This means that the levels must be integrat-
ed over time (for example, over the course of 24 h). This necessitates
knowing the total volume of sewage sampled from during the sam-
pling period. Fluctuations in CoP levels in sewage inﬂuent can result
from: (i) changes in per capita daily excretion (e.g., as a result of
changes in diet or health), (ii) change in population (e.g., transient
inward or outward migration from the STP service area), or (iii)
changes in sewage ﬂow (e.g., wet-weather events; episodic industrial
discharges; inﬁltration/exﬁltration). Knowing the ﬂux serves to
normalize for the changes in ﬂow. Otherwise, no conclusions can
be drawn whether CoP concentrations vary or are the same across
different STPs.
Signiﬁcantly, in no case were CoP concentrations in sewage avail-
able together with both daily sewage ﬂow rates and estimated popu-
lation served by the STP. This would have allowed calculation of
estimated daily per capita excretion rates to see if they were consis-
tent with the data summarized in Table 2. Furthermore, much of the
published data does not include adequate explanation as to how
particulates and suspended solids were handled during sampling or
sample preparation. So it is unclear if the reported sewage levels
reﬂected total or dissolved CoP levels (or portions of both).
Only a brief overview of some of the data on CoP in sewage will be
summarized below. One indication of CoP's potential utility as a sur-
rogate measure of population would be the variance in sewage levels
over time. Given the three major drivers for variance, if time-course
samples from a given STP were to show low variance, this would sup-
port the potential for CoP as a surrogate measure.
There have been few time-course studies of CoP in sewage. One of
the ﬁrst was published in 1970 (Tabak and Bunch, 1970). Weekly
sampling over 6 weeks for the STP inﬂuent and efﬂuent streams for
a Burlington (Iowa) STP gave CoP inﬂuent levels of 245–394 μg/L
(mean=316) and efﬂuent levels of 160–315 μg/L (mean=240);
efﬂuent levels, however, would be of limited use for ASAP-SCIM
(see Section 3.2.8). A subsequent 1972 study was one of the most
extensive time-course studies (Tabak et al., 1972). It followed CoP
levels in STP efﬂuents discharging on three to six dates from ﬁve
STPs along the Mississippi River. To illustrate the surprisingly small
intra-STP variance, the ranges and means [μg/L] were: Sioux City
(636–793, 709), Omaha (743–864, 797; 250–363, 312), St. Joseph
(391–484, 436; 465–573, 508; 365–498, 424; 424–535, 491), Kansas
City (496–587, 535; 259–319, 290; 328–419, 381), and Burlington
(245–394, 316; 160–315, 240). Dual-date sampling from single efﬂuents
from four STPs along the Ohio River yielded mean CoP levels (μg/L) for:
Little Miami (209), Mill Creek (633), Bromley, KY (355), and Muddy
Creek (291). The grand mean was 433 μg/L.
Another time-course study followed the weekly variation in CoP
in raw sewage from an STP in Honolulu. CoP ranged from 90 to
16 C.G. Daughton / Science of the Total Environment 414 (2012) 6–21381 μg/L (mean of 217) over an 11-month period (Brostrom, 2005);
CoP in the treated efﬂuent averaged 138 μg/L. A recent 1-year time-
course study followed CoP in the inﬂuent from two STPs in Hungary
(Andrási et al., 2011). Levels for one STP were 180, 302, and 45 μg/L
and for the other were 188, 100, 144, 44, 31, and 20 μg/L, giving an
overall combined range of 20–302 μg/L.
Numerous studies report CoP levels from single samples. These
studies illustrate the extremes in the CoP levels encountered in STPs
from different countries and from the use of different sampling and
analysis methodologies. CoP in the inﬂuent for ﬁve STPs in Tokyo
averaged 327 μg/L (Isobe et al., 2004). Inﬂuent to a small rural STP
in France (capacity of 1800 equivalent-inhabitants) had a CoP con-
centration of 98.7 μg/L (Jeanneau et al., 2011). Ten wastewater sam-
ples from urban STPs in Hungary had CoP levels ranging from 930
to 5360 μg/L (with a mean of 3010±1690 μg/L) (Szucs et al., 2006).
A back-of-the-envelope calculation provides some perspective for
comparison of measured CoP levels in sewage with what might be
predicted from known excretion rates. Using the general range for
per capita CoP excretion of 200–700 mg/day (derived from Table 2)
and using a very rough estimate of per capita daily water usage of
100 gal/day [379 L/day (USEPA, 2011)], a projected range of CoP load-
ings in sewage inﬂuent could be 527–1850 μg/L (assuming inﬂuent
comprises solely domestic waste). This is consistent with the pub-
lished data (Table 2) and again points to the possible utility of CoP
as a biomarker for the ASAP-SCIM concept.
These levels are of course sensitive to a broad spectrum of variables,
including water usage (which can vary dramatically by geographic
locale, season, and family), water wastage (e.g., plumbing leaks), com-
bined sewer inputs (e.g., industry, agriculture, wet weather, runoff of
animal feces), infrastructure deterioration resulting in alterations in
sewer ﬂows (e.g., inﬁltration/exﬁltration) (e.g., Shelton et al., 2011),
and CoP losses during transit to the STP (e.g., biodegradation). This
shows the importance of knowing the actual ﬂux of sewage for each
STP.
3.2.8. CoP in treated sewage
Numerous studies provide data on CoP (and sterols in general) in
treated sewage. These data are often collected as part of a study asses-
sing the occurrence and distribution of CoP in surrounding waterways
and sediments — primarily to assess sewage incursion or bacterial
source tracking. In general, CoP levels in treated sewage are substantially
reduced comparedwith raw inﬂuent, partly as a result of biodegradation
but primarily because of removal by sorption to sludge. Although these
data are much less useful to the SCIM application, they do serve to em-
phasize the need for sampling the inﬂuent to STPs as early in the process
stream as possible.
In a survey of efﬂuents from 10 STPs in the U.S., CoP was detected
in only 82% of samples. The median level was 1.3 μg/L and the
maximum was 5.9 μg/L (Glassmeyer et al., 2005). In 10 efﬂuents
from different STPs, CoP was detected in only one sample, at a level
of 140±10 μg/L (Moliner-Martinez et al., 2010).
4. Other potential markers
Any number of other chemical substances exist that could be con-
sidered as proxy markers for population size. Possible candidates
come from the universe of both naturally occurring and synthetic
xenobiotics (and their metabolites or formulation impurities) as
well as products of endogenous metabolism. Most markers have
been pursued as a means of source tracking for sewage or as an over-
all index for human activity or impact. Caffeine is a well-known
example (e.g., Froehner et al., 2010). But a variety of other chemicals
have also been assessed, including drugs [e.g., carbamazepine (Gasser
et al., 2011)], biocides [e.g., triclosan (Singh et al., 2010)], chemicals in
household cleaning agents [e.g., ﬂuorescent whiteners, trialkylamines(Managaki et al., 2006; Valls et al., 1989)], and food additives [e.g., su-
cralose (Oppenheimer et al., 2011)].
All consumer chemicals, however, lack at least several of the attri-
butes listed in Table 1, serving to either confound data interpretation
or render data excessively inaccurate. Sucralose is an example that
illustrates the problems also posed by other consumer chemicals,
including pharmaceuticals. Sucralose is a tri-chlorinated disaccharide
artiﬁcial sweetener that is refractory to metabolism and initial micro-
bial degradation. Although this would make sucralose an excellent
stable sewage tracer, its loadings into sewage are a function of vari-
ables that contribute excessive uncertainties. Among these are local/
regional culinary and nutritional preferences and customs. The use-
fulness of synthetic markers such as sucralose would depend on the
consistency of their market penetration; but the popularity of any
commercial product can vary widely. Its consumption can vary wide-
ly not just geographically but also over time. Per capita consumption
must be known in advance, and consumption rates are subject to
change as the chemical's popularity waxes and wanes. Although
these chemicals may prove useful for tracking contamination of
open waters back to the sewage sources and for deducing per capita
consumption (assuming the population is already known) (e.g., Lai
et al., 2011; Oppenheimer et al., 2011), they are not useful for ab initio
estimates of population size.
Chemicals involved in endogenous metabolism (products of bio-
synthesis or catabolism) avoid many of the problems of xenobiotics
for use as proxy measures since their association with per capita ac-
tivities has higher ﬁdelity. The main problems are those of excessive
intra- and inter-individual variation in excretion. This was documen-
ted in Section 3.1 (Creatinine as a possible biomarker for estimating
population) for creatinine, a marker long assumed to have a relatively
stable excretion rate across entire populations.
Problems other than variation in excretion rate confront possible
markers originating from endogenous metabolism. An example is a
biochemical relatively unique to human metabolism and which at
ﬁrst might appear to be a good candidate proxy marker — namely,
1-aminopropan-2-one (1-aminopropanone: APR; 1-aminoketone).
APR, via 1-aminopropan-2-ol, serves as a precursor to vitamin B-12
(Fitzsimons and Belt, 2005) and is very water soluble; it is excreted
in urine but in daily quantities much lower than CoP (e.g., Dawit et al.,
2001; Fitzsimons et al., 1995). The data regarding its levels in sewage,
although limited, are contradictory. It is sometimes found in sewage
at levels higher than in urine, with implications of perhaps de novomi-
crobial formation in sewage (Dawit et al., 2001; Fitzsimons and Belt,
2005; Fitzsimons et al., 1995); but other times it cannot be detected
(Singh and Gardinali, 2006).
5. The challenge of representative sampling
The focus of this paper is on the rationale for selecting appropriate
biomarkers excreted into sewage as a means for gauging the size of
small-area populations. Chief among the selection factors are minimal
intra- and inter-individual variance in excretion (Table 1). It cannot
be overemphasized, however, that many other parameters unrelated
to physiology and metabolism can contribute to possibly large short-
term and longer-term variance, especially in the sampling and analyti-
cal processes required for measuring the daily excreted quantities of a
given biomarker.
The uncertainty surrounding the sampling process itself could
prove to be the largest source of variance in measuring biomarker
loadings in sewage. This variance can originate from two critical
needs: (i) obtaining sewage samples that are representative in
space and time, and (ii) measuring the total ﬂow of sewage across
the time span over which the sampling occurs. These two factors
pose considerable challenges. Because of their complexity, they will
not be examined in any depth here. Indeed, the complexity of these
challenges has prevented nearly all published studies on quantifying
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pling approaches applicable to the wide spectrum of sewer system
designs and hydraulics (e.g., varied extents of pressurized connec-
tions, associated pumping and retention volumes, and mixing dy-
namics, and their inﬂuence on transient, intermittent pulsatile ﬂows
such as from the ﬂushing of individual toilets). To accommodate for
this considerable uncertainty, a conservative approach would be the
use of high-frequency, ﬂow-proportional sampling for acquiring
daily composite samples (Ort et al., 2010b). A possible alternative
would be continuous passive samplers, such solid phasemembrane de-
vices (SPMDs) or the polar organic chemical integrative sampler
(POCIS) (Harman et al., 2011). It is unknown, however, as to whether
highly hydrophobic biomarkers such as coprostanol would remain
sorbed to suspended solids rather than partition to the sampling device;
very few studies using SPMD or POCIS have reported on the extraction
of coprostanol, so it is unknown whether this approach would work in
the presence of suspended solids (e.g., Moliner-Martinez et al., 2010;
Rujiralai et al., 2011).
One sewage sampling problem would be somewhat ameliorated
with respect to monitoring an endogenous biomarker versus a xeno-
biotic (e.g., drugs or other so-called emerging contaminants) — the
latter of which have been the subject of most published studies. It
would be expected that the occurrence frequency for biomarkers
would be a higher, as they would originate from a larger percentage
of toilet ﬂushes than would xenobiotics; this is because biomarkers
undergo continual excretion across a larger percentage of the popula-
tion. Therefore, the sampling frequency should be less affected by the
need to ensure complete capture of pulsatile ﬂows.
Published studies have also limited themselves almost exclusively
to those chemicals that would be expected to be fully dissolved in the
aqueous phase — to avoid the considerable additional problems asso-
ciated with sampling suspended solids. Extensive examination of the
problems surrounding sampling uncertainty as applied to water-
soluble contaminants (but not hydrophobic analytes) in sewage has
been published by Ort et al. (2010a; 2010b).
Yet another problem would be in locating the point of sampling. If
suspended solids must be captured, the sampling location would
need to be in the inﬂuent, prior to clarifying. Although obtaining a
representative 24-h sample of the dissolved phase of sewage faces
many challenges itself, the problem is greatly magniﬁed by needing to
also ensure that suspended solids are captured representatively — as
might be required for a biomarker such as coprostanol. This problem re-
sults primarily from the possibility of cross-sectional non-homogeneity
of ﬂow in sewers, especially in open-channel sewers. Problems associat-
edwith suspended solids are discussed by Larrarte (2008). For these rea-
sons, the ASAP-SCIM concept presented heremight require considerable
further development before reliable implementation could begin.
Another problem relates to the reality that any given spatial seg-
ment of sewage ﬂow captures excreted materials from only a portionTable 3
Major steps required for validating SCIM concept for estimating population size by monitor
Milestone Rationale
Adopt/develop sewage sampling methodology Must accommoda
Adopt/develop and standardize analytical methodology Method would id
parameters suc
Identify suitable number of STPs in a variety of geographic locales for
acquiring test samples
STPs must span a
measures of the
Acquire CoP ﬂux data from each STP Using the monito
known populat
Acquire time-series data from select individual STPs Evaluate variation
from the measu
ﬂuctuations
Establish “reference ranges” of per capita daily excretion This will entail an
serving establis
Perform sensitivity and uncertainty analyses Establish those vaof the population served during that period of time— and this portion
is not known. But assuming that each individual excretes a particular
quantity of CoP over a 24-h period, then by monitoring CoP in the
sewage stream for an STP over successive 24-h periods, the ﬂux (con-
centration multiplied by ﬂow rate: ng/L×L/day) gives a series of daily
values for mass per day (e.g., ng/day). The running average then de-
volves to the per capita level.
Finally, with respect to the problems associated with measuring
sewer ﬂows, the effect of ﬂow pulses will depend in part on whether
a pipe is operated under pressure and how full non-pressurized pipes
are. Spatiotemporal variabilities in sewerage systems and ﬂows,
coupled with the heterogeneity introduced not just by the pulsatile
nature of sewage ﬂow but also by wet-weather ﬂows in combined-
sewers, pose great challenges to ﬂow measurement. The use of in-
line ﬂow sensors may help in this regard (Larrarte, 2008). Other
emerging technologies may eventually contribute to the better esti-
mation of ﬂows. One example is the development of real-time mea-
surement of local rainfall at higher spatial resolutions than currently
possible - with the use of mobile phone networks (Goldshtein et al.,
2009; Ryser and Bryner, 2010).6. Next steps
To further develop the SCIM concept for estimating population by
monitoring for coprostanol, a series of possible milestones can be
foreseen. These are summarized in Table 3.7. ASAP-SCIM and the future
Three emerging areas of advancement can be seen as greatly im-
proving the potential utility of the ASAP-SCIM concept; these are pre-
sented in the following sections.7.1. Automated, in-line, real-time measurement
If ASAP-SCIM using a suitable biomarker proves successful for
estimating small-area population size, its utility could be greatly
extended with in-line sensors (for measuring both biomarker levels
and sewage ﬂow rate). These outputs could be used to calculate
population in real time. Placed at strategic locations in a sewage
collection system, a network of sensors could provide data on increas-
ingly ﬁner scales. The ebb and ﬂow (efﬂux and inﬂux) of small-area
populations could even be visualized— in a format analogous to weath-
er maps. Successively larger, city-wide and regional populations could
be automatically estimated simply by summing the constituent small-
area populations.ing for coprostanol or other biomarkers.
te solids. Preferably ﬂow-proportional and time-integrated to acquire 24-h samples
eally be suitable for automation; determine analytical ﬁgures of merit and whether
h as metabolic conjugation are important to accommodate
broad range of populations served, and the error associated with the established
population sizes must be well known and understood
red CoP ﬂuxes, calculate the estimated per capita contributions for each STP using
ion sizes. Determine the variance among STPs
in data with time (daily, weekly, monthly). A portion of data variance will originate
rement methodology and another portion from actual de facto population
iterative process of repeated sampling at a sufﬁcient number and diversity of STPs
hed populations
riables contributing the most error and take measures to reduce them
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Uncertainty in measured levels of any biomarker (including
coprostanol) will always exist because of the numerous variables
driving the variance in biological systems. This uncertainty could
possibly be reduced by measuring additional biomarkers. An algo-
rithm could be developed for generating a composite population-
proxy index based on multiple biomarkers. This approach could be
guided by selecting biomarkers that are biased by different variables
(complementary) or biased in different directions by the same vari-
able (orthogonal). For example, two biomarkers could be selected
whose excretion rates are known to change in opposite directions
as a function of a given variable, such as age, gender, or diet. This
might serve to smooth the errors associated with their independent
per capita excretion rates.
7.3. Facilitating new uses for de facto population estimates— gauging the
health of communities
Finally, the availability of real-time population levels for discrete
geographic locales could be used to provide real-time estimates of
per capita consumption and production statistics for any number of
chemicals or non-chemical environmental stressors of human origin
and which can be measured in sewage. Examples include per capita
consumption (or disposal) of household chemicals, pharmaceuticals
(including illicit drugs), and personal care products, or per capita pro-
duction of endogenous biomarkers indicative of disease or health.
An emerging example of the need for better population estimates
is the growing number of studies applying the FEUDS methodology
for gauging community-wide consumption of illicit drugs. Inaccurate
population estimates are a major source of error in estimating aver-
age per capita usage (Daughton, 2011).
Although FEUDS represents the ﬁrst use of sewagemonitoring for
mining useful chemical information attributable to the collective
contributions from individuals in deﬁned populations, countless
other applications can be foreseen whose value would be enhanced
with the ability to allocate, apportion, or attribute on a per capita
basis. First noted by Daughton (2011), SCIM as a general approach
holds the potential for mining a wealth of information from sewage
in the form of biomarkers that reﬂect general or speciﬁc aspects of
health or disease. These data would require normalization on a per
capita basis, in a manner analogous to the conventional measure-
ment of urinary markers as implemented in clinical chemistry. This
new measurement ability would create the ﬁrst opportunity to
view and treat communities from a new perspective — by deﬁning
the community at large as the patient. Such an application would
represent the ﬁrst true implementation of “sewer epidemiology”
(Daughton, 2011).
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